Anti-inflammatory Effect of Bear's Gall in Rat Microglia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We hypothesize that bear's gall may have a certain role in anti-inflammation through a preventive effect of pro-inflammatory potentials. Secondly, we tried to connect the experimental results to Alzheimer's disease (AD), which chronic inflammation is a main cause of the disease. For this theme, we designed to elucidate the efficacy of bear's gall in suppressing the pro-inflammatory mediators, such as nitric oxide (NO) and interleukin-1β (IL-1β) in rat microglia. From the study, we concluded that bear's gall plays a positive role in suppressing such pro-inflammatory repertoire from rat microglia comparing to normal and positive control, such as culture media and cyclosporine. Interestingly, bear's gall showed a prolonged effect of anti-inflammation comparing with cyclosporine when time goes by up to 48h with a significant suppression at 1.2 ㎎/㎖. Therefore, we can consider that bear's gall in part can be applied to AD therapy in that it suppresses the expression of pro-inflammatory mediators as well as its continued effect.
Abstract
We hypothesize that bear's gall may have a certain role in anti-inflammation through a preventive effect of pro-inflammatory potentials. Secondly, we tried to connect the experimental results to Alzheimer's disease (AD), which chronic inflammation is a main cause of the disease. For this theme, we designed to elucidate the efficacy of bear's gall in suppressing the pro-inflammatory mediators, such as nitric oxide (NO) and interleukin-1β (IL-1β) in rat microglia. From the study, we concluded that bear's gall plays a positive role in suppressing such pro-inflammatory repertoire from rat microglia comparing to normal and positive control, such as culture media and cyclosporine. Interestingly, bear's gall showed a prolonged effect of anti-inflammation comparing with cyclosporine when time goes by up to 48h with a significant suppression at 1.2 ㎎/㎖. Therefore, we can consider that bear's gall in part can be applied to AD therapy in that it suppresses the expression of pro-inflammatory mediators as well as its continued effect.
참고문헌 (27)
- "interaction of human postmortem microglia with antibody-opsonized amyloid beta peptide", 70, pp.599~610 (2002)
- "Microglia and cytokines in neurological disease with special reference to AIDS and Alzheimer's disease", pp.75~83 (1993)
- "The molecular pathology of Alzheimer's disease", pp.487~498 (1991)
- "Key factors in Alzheimer's disease", 11, pp.1~11 (2001)
- "Cytotoxicity of microglia", 7, pp.111~118 (1996)
- "Ameboid microglia as effectors of inflammation in the central nervous system", pp.155~171 (1987)
- "Interleukin-1 of the central nervous system is produced by ameboid microglia" (1986)
- "A novel role for ursodeoxycholic acid in inhibiting apotosis by modulating mitochondrial membrane perturbation", 101(12), pp.2790~2799 (1998)
- "Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain Role of microglia", 20, pp.6309~6316 (2000)
- "Neurotrophic and neurotoxic effects of amyloid β protein Reversal by tachykinin neuropeptide", pp.279~282 (1990)
- "Current theories for the molecular and cellular pathogenesis of Alzheimer's disease Expert review in molecular medicine" (2001), Cambridge University Press
- "Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid Repression of the IFN- gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway", 156, pp.1601~1608 (1996)
- "Dirrefntial effects of chenodeoxycholic and ursodeoxycholic acid on interleukin-1 and tumor necrosis factor-αproduction by monocytes", pp.719~6 723 (1992)
- "The immunosuppressive effect of ursodexycholic a comparative in vitro study on human peripheral blood mononuclear cells", pp.165~172 (1993)
- "Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages", 39(3), pp.475~478 (1996)
- "Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells", 272, pp.29390~29397 (1997)
- "Activation of Macropharge CD8 Pharmacological Studies of TNF and IL-1β Production", 164, pp.1783~1792 (2000)
- "Selective upregulation of inducible Nitric Oxide Synthase and cytokines in microglia", 32, pp.51~59 (2000)
- "Activation of microglia cell by β-amyloid protein and interferon-γ", 374, pp.647~650 (1995)
- "Inflammatory cytokines within the central nervous system and mechanism of action", pp.~16 (1992)
- "Interleukin-1beta attenuates excitatory amino acid-induced neurodegeneration in vitro involvement of nerve growth factor", 153, pp.3468~3474 (1995)
- "Imflammatory receptories of Alzheimer's disease and non demented elderly microglia in vitro", 35, pp.72~79 (2001)
- "Glial cytokines in Alzheimer's disease", 26, pp.816~823 (1995)
- "Expression of amyloid precursor protein mRNAs in endothelial modulation by interleukin-1", pp.128~134 (1992)
- "Glial cytokines in Alzheimer's disease", 26, pp.816~823 (1995)
- "In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis", 17, pp.761~766 (1996)
- "a reassessment of the evidence in the light of recent discoveries", 59, pp.13~23 (2000)